Reply to I.H.I.M. Hollink et al

Journal of Clinical Oncology

Volumn 28, Issue 28, 2010, Pages

  Damm, Frederik ^a   Heuser, Michael ^a   Ganser, Arnold ^a   Krauter, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYTARABINE; FLT3 LIGAND; MIXED LINEAGE LEUKEMIA PROTEIN; NUCLEOPHOSMIN; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; CYTOGENETICS; DRUG SENSITIVITY; EXON; GENE DUPLICATION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; INTERNAL TANDEM DUPLICATION; KARYOTYPE; LETTER; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79951861491     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.8398     Document Type: Letter

References (15)

1. Hollink IHIM, van den Heuvel-Eibrink MM, Zimmerman M, et al: No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia. J Clin Oncol 28:e523-526, 2010
2. Damm F, Heuser M, Morgan M, et al: Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. J Clin Oncol 28:578-585, 2010
3. Döhner K, Schlenk RF, Habdank M, et al: Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations. Blood 106:3740-3746, 2005 (Pubitemid 41739007)
4. Hollink IH, Zwaan CM, Zimmermann M, et al: Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia 23:262-270, 2009
5. Balgobind BV, Hollink IH, Reinhardt D, et al: Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique. Eur J Cancer doi:10.1016/j.ejca.2010.02. 019 [epub ahead of print on March 15, 2010]
6. Schlenk RF, Döhner K, Krauter J, et al: Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358:1909-1918, 2008
7. Döhner K, Tobis K, Ulrich R, et al: Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: A study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 20:3254-3261, 2002 (Pubitemid 34831523)
8. Paschka P, Marcucci G, Ruppert AS, et al: Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study. J Clin Oncol 26:4595-4602, 2008
9. Virappane P, Gale R, Hills R, et al: Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 26:5429-5435, 2008
10. Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, et al: Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. Blood 113:5951-5960, 2009
11. Hou HA, Huang TC, Lin LI, et al: WT1 mutation in 470 adult patients with acute myeloid leukemia- stability during disease evolution and implication into a survival scoring system. Blood doi:10.1182/blood-2009-12-259390 [epub ahead of print on April 5, 2010]
12. Ho PA, Zeng R, Alonzo TA, et al: Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. Blood doi:10.1182/blood-2010-02-268953 [epub ahead of print on April 22, 2010]
13. Gaidzik VI, Schlenk RF, Moschny S, et al: Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: A study of the German-Austrian AML Study Group. Blood 113:4505-4511, 2009
14. Abbas S, Erpelinck-Verschueren CA, Goudswaard CS, et al: Mutant Wilms' tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD). Leukemia 24:660-663, 2010
15. Ma W, Kantarjian H, Xi Z, et al: Mutation and single-nucleotide polymorphism (rs16754) in Wilms-tumor-1 gene are independent prognostic factors in acute myeloid leukemia. Presented at Am Soc Hematol 51st Annual Meeting, New Orleans, LA, December 5-8, 2009